Back

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

2020-08-07 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

ObjectiveTo assess adverse events and safety of aripiprazole and olanzapine treatment. MethodsTwenty-four healthy volunteers receiving 5 daily oral doses of 10 mg aripiprazole and 5 mg olanzapine in a crossover clinical trial were genotyped for 46 polymorphisms in 14 genes by qPCR. Drug plasma concentrations were measured by HPLC-MS/MS. Blood pressure and 12-lead ECG were measured in supine position. Adverse events were also recorded. ResultsAripiprazole decreased diastolic blood pressure on t...

Predicted journal destinations